Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
13.26 USD | +1.69% | +2.39% | -11.01% |
01.04. | Elanco Animal Health beruft zwei von Ancora Holdings nominierte Mitglieder in den Vorstand | MT |
01.04. | Elanco ernennt zwei Direktoren nach der Einigung mit dem Aktivisten Ancora | RE |
Kurzporträt
Mitarbeiterzahl: 9 550
Umsatz nach Geschäftsbereich
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
Pet Health
47,6
%
| 2 138 | 48,5 % | 2 104 | 47,6 % | -1.59% |
Farm Animal - Cattle
21,5
%
| 944 | 21,4 % | 949 | 21,5 % | +0.53% |
Farm Animal - Poultry
17,3
%
| 716 | 16,2 % | 765 | 17,3 % | +6.84% |
Farm Animal - Swine
8,6
%
| 384 | 8,7 % | 382 | 8,6 % | -0.52% |
Farm Animal - Aqua
4,0
%
| 175 | 4,0 % | 175 | 4,0 % | 0.00% |
Contact Manufacturing
1,0
%
| 54 | 1,2 % | 42 | 1,0 % | -22.22% |
Umsatz je Region
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
International
55,1
%
| 2 446 | 55,5 % | 2 434 | 55,1 % | -0.49% |
United States
44,9
%
| 1 965 | 44,5 % | 1 983 | 44,9 % | +0.92% |
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Jeffrey Simmons
CEO | Chief Executive Officer | 56 | 01.07.18 |
Todd Young
DFI | Director of Finance/CFO | 52 | 14.12.18 |
Chief Tech/Sci/R&D Officer | - | - | |
David Kinard
ADM | Chief Administrative Officer | 57 | 01.07.18 |
Kathryn Grissom
IRC | Investor Relations Contact | - | - |
Ben Kruse
PRN | Corporate Officer/Principal | - | 08.08.22 |
Rajeev Modi
PRN | Corporate Officer/Principal | - | - |
Corporate Officer/Principal | - | - | |
James Meer
AUD | Comptroller/Controller/Auditor | 54 | 24.09.18 |
Ramiro Cabral
PRN | Corporate Officer/Principal | 52 | 01.01.98 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Bill Doyle
BRD | Director/Board Member | 61 | 14.12.20 |
Art Garcia
BRD | Director/Board Member | 62 | 08.05.19 |
John Bilbrey
BRD | Director/Board Member | 68 | 11.03.19 |
Lawrence Kurzius
BRD | Director/Board Member | 66 | 01.09.18 |
Deborah Kochevar
BRD | Director/Board Member | 67 | 11.03.19 |
R. Hoover
CHM | Chairman | 77 | 01.05.18 |
Kapila Anand
BRD | Director/Board Member | 70 | 01.09.18 |
Director/Board Member | 64 | 11.03.19 | |
Jeffrey Simmons
CEO | Chief Executive Officer | 56 | 01.07.18 |
Director/Board Member | 61 | 01.09.18 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 494 097 056 | 490 911 256 ( 99,36 %) | 0 | 99,36 % |
Unternehmenskontakt
Konzerngesellschaften
Name | Kategorie und Branche |
---|---|
Eli Lilly Trading SA
| |
Elanco India Pvt Ltd.
Elanco India Pvt Ltd. Food: Major DiversifiedConsumer Non-Durables Part of Elanco Animal Health, Inc., Elanco India Pvt Ltd. is a world leader in developing innovative products and solutions that enhance animal health. The private company is based in Mumbai, India. Elanco's values guide the way they work at every level, including through the governance of their Executive Committee and Board of Directors. Elanco offers a variety of products and solutions to veterinarians and farmers to help care and raise healthy animals. |
Food: Major Diversified
|
Elanco Financing (Netherlands) BV
Elanco Financing (Netherlands) BV Finance/Rental/LeasingFinance Part of Elanco Animal Health, Inc., Elanco Financing (Netherlands) BV provides financing and loans services and holding activities. The private company is located in Netherlands. |
Finance/Rental/Leasing
|
Elanco Austria GmbH
|
Sektor
Umsatz nach Geschäftsbereich
Umsatz je Region
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
-11.01% | 6.43 Mrd. | |
-19.73% | 70.08 Mrd. | |
+15.88% | 3.52 Mrd. | |
-2.92% | 3.11 Mrd. | |
-0.68% | 1.38 Mrd. | |
-17.27% | 1.37 Mrd. | |
-2.73% | 1.24 Mrd. | |
-14.67% | 1.13 Mrd. | |
-5.37% | 1.02 Mrd. | |
-24.06% | 838 Mio. |
- Börse
- Aktien
- A2N6BH Aktie
- Unternehmen Elanco Animal Health Incorporated